View Document Preview and Link Document Date: 2014-01-27 20:27:01 Open Document File Size: 1,12 MB Share Result on Facebook
Company Greystone Associates / GlaxoSmithKline / Javelin Pharmaceuticals / Direct-Haler A/S / ONdrugDelivery Ltd. / MG2 / PhD / Nastech Pharmaceutical Company Inc / CURRENTLY AVAILABLE SYSTEMS / Schering-Plough / AstraZeneca / DirectHaler Nasal / Novartis / / Country United Kingdom / / Currency USD / / / Event Force Majeure / FDA Phase / / Facility BUILDING FURTHER ON THE / Cedar Cottage / / / IndustryTerm pulmonary device technology / technology offers / pharmaceutical industry / mass production technology / pulmonary delivery applications / final delivery site / subjects products / unit-dose devices / issued device / nasal delivery technologies / manufacturing process / integrated nasal device / nasal delivery technology / nasal device technology / pain management applications / saline spray/drop solution / manufacturing simplicity / multi-use devices / blow energy / dry-powder pulmonary delivery technology / dry powder delivery device / supply chain / peptide products / biotechnology / suitable nasal delivery technology / pharmaceutical market niche / nasal products / liquid aerosol generation devices / lymphatic and immune systems / mulation technologies / nasal delivery device systems / nasal delivery device / nasal delivery systems / pharmaceutical / specialised equipment / respiratory pharmaceutical / nasal device / nasal drug delivery technologies / treatment of migraine / delivered products / treatment of breakthrough pain in cancer / therapeutic applications / formulation/device technology types / technology gap / / MedicalCondition early-morning motor dysfunction / arthritis / drowsiness / common cold relief / pulmonary deilvery / respiratory tract infection / chronic conditions / cancer / pulmonary administration / Direct-Haler’s dry-powder pulmonary delivery technology / diabetes / vomiting / latestage Parkinson’s disease / breakthrough pain / DirectHaler Pulmonary / diseases / nasal and pulmonary airhouse complete filling / pulmonary deposition / same blister / nausea / rhinitis / motion sickness / GALANTAMINE Dementia / MS / pulmonary delivery applications / device manratory infections / Alzheimer’s disease / acute oral poisoning / disease / migraine / pain / allergic rhinitis / pulmonary device technology / pulmonary drypowder inhalers / / MedicalTreatment HRT / hormone replacement therapy / pain management / drug therapies / / Organization NEW HORIZONS / IN administration / FDA / Intranasal administration / / Person Anthony P Sileno / Michael T Sheckler / Henry R Costantino / Guy Furness / Crystal Whitehead / Daniel Carr / Troels Keldmann / Douglas A Hamilton / Paul H Johnson / Fred Mermelstein / / / Position Managing Director / Representative / Senior Vice President / Research & Development and Chief Scientific Officer / Director / Clinical Affairs & Toxicology Paul / Director / Formulations; Paul H Johnson / Director / Clinical Affairs & Toxicology / Director / Formulations / / Product Imitrex / STADOL / Rhinocort / Nasonex / Flonase / NASCOBAL / Butorphanol tartrate / cyanocobalamin / Miacalcin / NASCOBAL® FDA / / ProvinceOrState Indiana / Sussex / / Technology DRUG DELIVERY / drug discovery / dry-powder pulmonary delivery technology / mulation technologies / biotechnology / nasal drug delivery technologies / pulmonary device technology / nasal device technology / pdf / pharmacokinetics / nasal delivery technologies / Drug Delivery Technology / nasal delivery technology / DirectHaler technology / DirectHaler technologies / suitable nasal delivery technology / mass production technology / / URL www.nastech.com / http / SocialTag 
Microsoft PowerPoint - Presentation2